Table 3.
Connexin | Action | TJ protein | Effects on |
Cell types | References | ||
---|---|---|---|---|---|---|---|
Protein expression | Barrier functiona | Ouabain effectsb | |||||
Cx26 | Expression | Claudin-4 | Caco-2 cells | [83] | |||
Expression | Claudin-14 | P | Calu-3 cells | [84] | |||
P | [85] | ||||||
Cx32 | Expression | Occludin, Claudin-1, Claudin-2, MAGI-1 | Cx32-deficient hepatocytes | [20] | |||
Expression | Occludin, Claudin-1, Claudin-2, MAGI-1 | Cx32-deficient hepatocytes | [21] | ||||
Expression | Occludin, Claudin-1, ZO-1 | Cx32-deficient hepatocytes | [80,85] | ||||
Expression | Occludin, Claudin-1 | Cx32-deficient hepatocytes (CHST8 and Cx32KOH) | [126] | ||||
Expression | Occludin, Claudin-1, Claudin-2, MAGI-1 | Cx32-deficient hepatocytes | [81] |
An increase in the barrier function of tight junctions corresponds to either an increase in transepithelial electrical resistance (TER) or a lowered paracellular flux of a solute.
P: protect disruption of barrier and fence functions of TJs by the Na+/K+-ATPase inhibitor ouabain.